2024 International Congress » Parkinson's Disease: Genetics

Meeting: 2024 International Congress

5HTTLPR (44bp Ins/Del) polymorphism: Serotonergic subtype of Parkinson’s Disease

T. Syed, R. Kandadai, S. Yaranagula, T. Sd, S. Mohareer, S. Kola, R. Alugolu, R. Borgohain (Hyderabad, India)

7year followup of Asia’s first case of sporadic ATP6AP2 Mutation: α-synucleinopathy or tauopathy?

K. Shukla, N. Sawal, A. Prasad (Mohali, India)

A Benign Course of Parkinson’s Disease Associated with Different Mutations in the Glucocerebrosidase (GBA) Gene – a Case Series.

M. Cohen, Y. Schechter, R. Eichel, G. Yahalom (Jerusalem, Israel)

A Case of Paradoxical Gait Response to Levodopa in Parkin-Gene-Related Early-Onset Parkinson’s Disease

D. Naheed, A. Mehta, S. Neo, L. Tan (Singapore, Singapore)

A new phenotype-genotype correlation for FIG4 gene and Parkinson’s disease

I. Boura, G. Xiromerisiou, I A. Giannopoulou, P. Mitsias, C. Spanaki (HERAKLION, Greece)

A Rare Case of Parkinson’ s Disease Associated With Heterozygous ATP13A2 Gene Mutation: What If There Are No Atypical Features with a Later Onset?

Y. Degirmenci (Istanbul, Turkey)

A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

Adding Parkinsonism to the Phenotypic Spectrum of FIG4-related diseases

K. Pyle, G. Pawar, J. Frey (Morgantown, USA)

Artificial intelligence: a potential predictor of GBA1-mutated genotype in Parkinson’s Disease patients?

G. Di Rauso, A. Ghibellini, S. Grisanti, F. Cavallieri, V. Fioravanti, E. Monfrini, G. Toschi, G. Portaro, J. Rossi, R. Sabadini, L. Gherardini, C. Lucchi, G. Biagini, L. Bononi, M. Gabbrielli, A. Di Fonzo, F. Valzania (Reggio Emilia, Italy)

Assessing Genome-wide Genetic Risk for Parkinson’s Disease in European Sub-Populations Across the Global Parkinson’s Genetics Program and National Biobanks

G. Lobal_parkinson'S_genetics_program (gp2) (Bethesda, USA)

Association between Genetic Polymorphisms and Disease Progression in Parkinson’s disease

TC. Fang, YJ. Guo, MH. Chang (Taichung, Taiwan)

Association of Gaucher-related and Parkinson’s-private GBA1 variants with progression of PD: A longitudinal mixed model analysis.

A-M. Hanff, C. Mccrum, A. Rauschenberger, S. Pachchek, G. Aguayo, C. Pauly, S. Jónsdóttir, O. Tsurkalenko, L. Pauly, Z. Landoulsi, A. Leist, P. May, M. Zeegers, R. Krüger (Strassen, Luxembourg)

Association of Impulse Control Disorder with GRIN2B Gene Polymorphisims in Parkinson Disease

G. Memari, E. Erzurumluoglu, N. Durmaz Celik, S. özkan, S. Artan (Eskisehir, Turkey)

Association of polygenic risk score of the LRRK2 gene for Parkinson’s disease with lysosomal hydrolase activities in the Russian Population based on genetic profile and established risk factors

T. Usenko, K. Basharova, A. Bezrukova, K. Senkevich, I. Miliukhina, A. Timofeeva, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

Bidirectional Relationship Between Olfaction and Parkinson’s Disease

J. Kim, S. Bandres-Ciga, K. Heilbron, 23. INC., C. Blauwendraat, A. Noyce (London, United Kingdom)

Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson’s disease

Y. Li, J. Liu, L. Wu (shanghai, China)

Causal effects of sarcopenia-related traits on risk and progression of Parkinson’s disease: a Mendelian randomization study

T. Wang, J. Geng, R. Han, X. Zeng, J. Peng, YE. Huh (Xi’an, China)

Clinical And Genetic Analysis Of Patients With Parkinson’s Disease -LRRK2 Variants From A Referral Centre In India

S. Rath, PK. Pal, R. Yadav, VV. Holla, N. Kamble (MUMBAI, India)

Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest of China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients

YF. Cheng, HF. Shang (Chengdu, China)

Clinical Features of dj1 Gene Mutation Causing Parkinson’s Disease from Single Institution

H. Alhodaif, Y. Alkhodair, A. Aldakheel, S. Alqahtani, S. Boholegah (Riyadh, Saudi Arabia)

Clinico-genetic profile of five patients with PARK-PINK1: A case series from India

A. Gunasekaran, P K. Pal, R. Yadav, N. Kamble, V. Holla (Bangalore, India)

Common Genetic Variation Associated with Parkinson’s Disease Biological Measures

EN. Somerville, K. Senkevich, M. Ta, E. Yu, H. Iwaki, Z. Gan-Or (Montreal, Canada)

Comorbidities in genetic Parkinson’s Disease: comparison between LRRK2, GBA1, and non-mutated PD

G. Di Rauso, F. Pirone, G. Franco, F. Arienti, I. Trezzi, E. Frattini, F. Cavallieri, V. Rispoli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)

Contribution of Genetics to Onset of PD with Leg Tremor

N. Becker, S. Shah, D. Raymond, M. Rawal, V. Katsnelson, K. Leaver, S. Bressman, R. Saunders-Pullman, C. Young, M. Yang (New York, USA)

Determining and Leveraging Local Ancestry to Assess Individual-Level Risk: from the Global Parkinson’s Genetics Program

G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)

Diagnosing Young-Onset and Familial Parkinson’s Disease Using an Extensive Targeted Panel

HL. Chiang, YC. Lee (Taipei, Taiwan)

Differences in Oculometric Measures between Patients with LRRK2-associated and Idiopathic Parkinson’s Disease

R. Djaldetti, E. Raveh, J. Reiner, L. Franken, E. Harpaz, R. Kreitman, E. Ben-Ami (Petah Tikva, Israel)

Disease Progression in Patients with PLA2G6-related Parkinsonism: A Longitudinal Study

YM. Sun, C. Chen, XY. Zhou, FT. Liu, JJ. Wu, J. Wang (Shanghai, China)

Distinct patterns of Gene Expression in Skin-biopsy Derived Fibroblasts of Patients with Parkinson’s disease

T. Ntetsika, I. Markaki, A. Damdimopoulos, M. Zeitelhofer, P. Tsitsi, M. Zeitelhofer Adzemovic, P. Svenningsson (Stockholm, Sweden)

Engagement of the Black and African American Community in Parkinson’s Genetic Research

E. Stevens, A. Kumeh, S. Sauveur, D. Oguoma-Richards, R. Huckabee, A. Huckabee, D. Coley, B. Coley, M. Fitts, E. Lewis, L. Seghetti, T. Best, K. Gamble, K. Williams, L. Wilson, R. Joseph, H. Shah, C. Gallagher, C. Evers, J. Beck, A. Naito, C. Branson (New York, USA)

Expanding Diversity of Parkinson’s Disease and Related Disorders Genetic Data: from the Global Parkinson’s Genetics Program

G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)

Expanding Phenotype of LRRK2 G2019S Mutation: Case Description of Two Sisters Showing Peculiar Phenomenological Traits

S. Cartella, S. Neri, G. Foti, G. Cartella (Reggio Calabria, Italy)

Expanding the PD GENEration Study to increase clinical genetic testing and counseling using whole genome sequencing among diverse Parkinson’s disease (PD) populations

K. Ghosh Galvelis, A. Naito, M. Dini, S. Rao, R. Deleon, A. Coral-Zambrano, T. Foroud, P. Hodges, L. Heathers, J. Verbrugge, L. Cook, J. Schulze, M. Totten, A. Hall, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, P. Ponger, J. Beck, R. Alcalay (New York, USA)

Expanding the Spectrum of Autosomal Recessive Genes Responsible for Parkinson’s Disease in the Chinese Population

Y. Zhao, H. Pan, J. Guo, Z. Liu, B. Tang (Changsha, China)

Exploring MAPT Haplotypes in Parkinson’s Disease in a Diverse Cohort: Insights from the Global Parkinson’s Genetics Program

P. Reyes-Pérez, J. Hor, A. Sanyaolu, T. Toh, K. Senkevich, H. Leonard, K. Brolin (Querétaro, Mexico)

Frequency of LRRK2 p.L1795F variant in Parkinson’s Disease patients from Central Europe within the CEGEMOD consortium

M. Ostrozovicova, G. Tamas, K. Soos, P. Dusek, M. Grofik, V. Han, P. Holly, R. Jech, P. Klivenyi, N. Kovacs, K. Kulcsarova, E. Kurca, A. Lackova, J. Necpal, D. Pinter, E. Ruzicka, T. Serranova, K. Smilowska, I. Straka, T. Svorenova, P. Valkovic, K. Zarubova, H. Houlden, M. Rizig, M. Skorvanek (Kosice, Slovakia)

Frequency of Variants of Uncertain Significance in a Cohort of Early-onset Parkinson’s Disease Patients

A. Zare Dehnavi, C. Piat, N. Niu, O. Ross, A. de Menezes, P. Gaia, R. Savica (Rochester, USA)

GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil

F. Rolim, S. Lima, A. Verde, P. Matos, A. Marinho, F. Carvalho (Fortaleza, Brazil)

GBA1 deficiency differentially affects endolysosomal trafficking in neurons and astrocytes

S. Fish, A. Khera, J. Weiss, A. Park, R. Estes, S. Yu, L. Pallanck, J. Young, M. Davis (Seattle, USA)

Genetic Analysis of Mendelian mutations in A Large Chinese Early-onset and Familial Parkinson’s Disease

F. Xie, XS. Zheng, W. Luo (Hangzhou, China)

Genetic determinants of the progression of Lewy body pathology

L. Wu, AL. Gil, T. Georgiades, E. Stafford, K. Levine, M. Tan, A. Martinez Carrasco, D. Gveric, N. Wood, C. Smith, A. King, S. Love, A. Robinson, L. Parkinnen, C. Morris, J. Tunold, M. Nalls, C. Blauwendraat, A. Singleton, G. Halliday, C. Shepherd, S. Gentleman, T. Warner, Z. Jaunmuktane, L. Pihlstrom, J. Hardy, T. Lashley, R. Real, H. Morris (London, United Kingdom)

Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population

H. Pan, L. Liu, J. Guo, B. Tang, Y. Zhao (Changsha, China)

Genetic Study of polymorphism of cytokines in Parkinson’s disease.

S. Frikha, O. Ben Othmen, S. Fezai, A. Achouri, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

Genome-wide Assessment of Homozygosity in Parkinson’s Disease Across Diverse Ancestral Population

K. Step, C. Hernandez Astudillo, E. Eltaraifee, Z-H. Fang, A. Hernández-Medrano, P-J. Kung, M. Ostrožovičová, A. Zirra, I. Sarmiento, S. Bandres-Ciga (Cape Town, South Africa)

Genome-Wide Association Study revealing novel risk loci associated with Age at Onset of Parkinson’s Disease

YS. Hwang, SY. Jo, SH. Lee, KY. Park, SJ. Chung (Jeonju, Republic of Korea)

Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease

S. Jo, J-H. Oh, J. Lee, S. Son, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

Implications of BSCL2 Mutation in the Pathogenesis of Parkinson’s Disease

AY. Regalado-Mustafá, CF. álvarez-Hernandez, WF. Moguel-Cardin, AL. Guerra-Anzaldo, A. Domínguez-García, MAG. Medrano-Delgado, AJ. Hernández-Medrano, A. Cervantes-Arriaga, A. Abundes-Corona, A. Guevara-Salinas, M. Rodríguez-Violante, N. Monroy-Jaramillo, LV. Adalid-Peralta (Mexico City, Mexico)

Increased alpha-internexin levels are associated with a higher risk of Parkinson’s disease

X. Guo, G. Tian, R. Zhou, R. Li (Xi'an, China)

Investigating Copy Number Variations in SNCA and PRKN in a Cohort of Kazakhstani Patients with Parkinson’s Disease and Healthy Controls

R. Kaiyrzhanov, N. Zharkynbekova, S. Abdraimova, C. Shashkin, Z. Myrzayev, A. Karimova, V. Akhmetzhanov, K. Mok, J. Hardy, H. Houlden (Shyment, Kazakhstan)

Investigating the genetic relationship between vitamin B12 deficiency and Parkinson’s disease

K. Senkevich, R. Dering, M. Onvumere, L. Liu, P. Huot, Z. Gan-Or (Montreal, Canada)

Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities

J. Kim, I. Foote, S. Bandres-Ciga, 23. Research Team, C. Marshall, A. Grotzinger3, A. Singleton, A. Brentnall, C. Blauwendraat, A. Noyce, G. Genetics Program (London, United Kingdom)

Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease

M. Lai, B. Benitez (Boston, USA)

Long-read sequencing to identify unrevealed second hit in autosomal recessive Parkinson’s disease

K. Daida, H. Yoshino, K. Billingsley, L. Malik, B. Baker, R. Genner, K. Paquette, M. Ishiguro, M. Funayama, Y. Li, K. Nishioka, C. Blauwendraat, N. Hattori (Bethesda, USA)

LRRK2 and GBA Founder Mutations and their Interactions in Parkinson’s Disease

M. Kmiecik, G. Riboldi, R. Schneider, K. Stagaman, T. Filshtein Sonmez, A. Guan, M. Wetzel, P. Fontanillas, M. Holmes, S. Aslibekyan, L. Norcliffe-Kaufmann (Sunnyvale, USA)

LRRK2 Gene Mutation in Parkinson’s Disease

A. Abbes, M. Mhiri, R. Ben Dhia, N. Gouta, M. Frih Ayed (Monastir, Tunisia)

LRRK2 in Parkinson’s Disease: A per-domain rare-variant burden study

S. Parlar, K. Senkevich, E. Yu, J. Ruskey, J. Ahmad, F. Asayesh, D. Spiegelman, C. Waters, O. Monchi, Y. Dauvilliers, N. Dupré, L. Greenbaum, S. Hassin-Baer, I. Miliukhina, A. Timofeeva, A. Emelyanov, S. Pchelina, R. Alcalay, E. Fon, Z. Gan-Or (Montreal, Canada)

Lysosomal network defects in parkinsonian patients carrying rare variants in lysosomal hydrolytic enzyme genes

J. Hoenicka, A. Pascual, O. de Fàbregues, M. Frias, L. Vela, M. de Lucca, P. García-Ruiz, C. Feliz, M. Marchen, R. Repossi, G. Fernández, M. Roldán, F. Palau (Esplugues de Llobregat, Spain)

MDSGene Update and Expansion: Clinical and Genetic Spectrum of LRRK2 Variants in Parkinson´s Disease

C. Krüger, S-Y. Lim, A. Buhrmann, FL. Fahrig, C. Gabbert, N. Bahr, H. Madoev, C. Marras, C. Klein, K. Lohmann (Luebeck, Germany)

Parkinson’s Families Project: A UK-Wide Study of Early Onset and Familial Parkinson’s Disease

R. Real, Z-H. Fang, C. Towns, T. Schmaderer, S. Jasaityte, M. Tan, M. Pollard, L. Lange, R. Tilney, A. Singleton, C. Blauwendraat, C. Klein, H. Morris (London, United Kingdom)

Parkinson’s disease associated SORL1 variants impair mitochondrial and endo-lysosomal function

Z. Liu, M. Zhao, Y. Zhao, J. Tan, B. Tang (Changsha, China)

Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)

Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation

J. Verbrugge, H. Oas, L. Cook, T. Schwantes-An, L. Walsh, T. Foroud, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, A. Hall, A. Naito, J. Beck, R. Alcalay (Indianapolis, USA)

PD GENEration: a genetic analysis beyond the classical 7 Parkinson’s disease genes

I. Keller Sarmiento, V. Pitz, C. Blauwendraat, Z. Fang, T. Tatiana Foroud, A. Hall, K. Marder, I. Mata, M. Nance, M. Schwarzchild, T. Simuni, A. Wills, S. Lawrence, K. Ghosh Galvelis, J. Beck, A. Naito, R. Alcalay, N. Mencacci (Chicago, USA)

Prevalence of Parkinson’s Disease and Possible Parkinsonian Syndrome in Gaucher Disease: Data From the ICGG Gaucher Registry

R. Alcalay, P. Mistry, A. Di Fonzo, J. Batista, P. Bianculli, J. Carwile, G. Perichon, M. Balwani (New York, USA)

RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features

R. Tilney, R. Real, E. Gustavsson, S. Jasaityte, Y. Kordovska, M. Fenn, P. Korlipara, M. Hu, E. Sammler, M. Farrer, H. Morris (London, United Kingdom)

RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)

C. Beetz, M. Radefeldt, K. Tripolszki, P. Bauer (Rostock, Germany)

Rare Variant Association Analysis in Kazakhstani Parkinson’s Disease Population: Preliminary Results from GP2 CAT-PD Study

M. Isayan, N. Zharkinbekova, S. Abdraimova, CH. Shashkin, ZH. Myrzayev, V. Akhmetzhanov, A. Karimova, M. Ganieva, Z. Tavadyan, S. Khachatryan, M. Beridze, S. Sopromadze, I. Khatiashvilli, M. Kekenadze, K. Ceferov, V. Escott-Price, J. Hardy, H. Houlden, R. Kaiyrzhanov (Yerevan, Armenia)

Rare Variant Burden is Increased in Sporadic Late-onset Chinese Parkinson’s Disease Patients

RWH. Ho, ZW. Xiong, RCN. Lo, HF. Liu, PWL. Ho, SL. Ho, SYY. Pang (Hong Kong, Hong Kong)

Readiness for genetic testing among Indian movement disorder patients:A tertiary centre experience

S. Kamath, V. Holla, N. Kamble, R. Mahale, R. Yadav, P. Pal (Bangalore, India)

Remote DNA Collection for Parkinson’s Research: Insights from AccessPD

Y-H. Chang, E. Shelton, H. Chohan, M. Periñan, A. Noyce (London, United Kingdom)

Screening for newly PD-associated RAB32 p.S71R variant in Latin America

M. Rivera Paz, E. Waldo, T. Leal, P. Reyes-Pérez, M. Inca-Martinez, S. Alcauter, I. Amorín, M. Cornejo-Olivas, E. Dieguez, I. Estrada-Bellmann, A. Hernández-Medrano, M. Jimenez-Del-Rio, A. Lescano, B. Muñoz Ospina, K. Nuytemans, J. Orozco, V. Raggio, M. Rentería, J. Rios-Pinto, M. Rodriguez-Violante, K. Salinas Barboza, A. Schuh, C. Velez-Pardo, I. Mata (Cleveland, USA)

Slc2a13, a risk gene for Parkinson’s disease associated with Snca and Lrrk2

JW. Li, GX. Zhang, T. Wang, ZC. Lin, N. Xiong (Wuhan, China)

Sleep Characteristics in Idiopathic and Genetic Parkinson’s Disease

A. Astefanous, M. Yang, D. Raymond, M. Rawal, J. Liang, A. Cohen, N. Becker, B. Plitnick, A. Yoo, V. Katsnelson, K. Leaver, S. Bressman, M. Figueiro, R. Saunders-Pullman, A. Wise (NEW YORK, USA)

Strategic Training Framework for Advancing Research Capacity through GP2

MT. Perinan, S. Dey, H. Leonard, M. Makarious, A. Martinez-Carrasco, A. Zirra, P. Reyes-Perez, P. Saffie Awad, A. Sanyaolu, P-J. Kung, Y-W. Tay, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Seville, Spain)

Studying monogenic Parkinson’s disease by building a global cohort of mutation carriers

L. Lange, J. Junker, E-J. Vollstedt, K. Roopnarain, M. Doquenia, A. Ahmad-Annuar, M. Avenali, S. Bardien, N. Bahr, M. Ellis, C. Galandra, T. Gasser, P. Heutink, A. Illarionova, Y. Kanana, I. Keller Sarmiento, K. Kumar, S-Y. Lim, H. Madoev, I. Mata, N. Mencacci, M. Nalls, S. Padmanabhan, C. Shambetova, J. Solle, A-H. Tan, J. Trinh, E M. Valente, A. Singleton, C. Blauwendraat, K. Lohmann, Z-H. Fang, C. Klein (Luebeck, Germany)

The association of Severity and Monogenetic Subgroups in Parkinson’s Disease

N. Pacheco-Barrios, K. Acurio, J. Rolston, T. Siepman, B. Illigens (Boston, USA)

The Black and African American Connections to Parkinson’s Disease Study

F. Akcimen, P. Crea, P. Saffie-Awad, S. Grant, R. Traurig, M. Khani, M. Makarious, K. Levine, D. Vitale, M. Koretsky, M. Nalls, Z. Fang, J. Solle, N. Louie, O. Ojo, N. Okubadejo, G. Sukumar, C. Dalgard, R. Real, H. Morris, K. Billingsley, P. Jerez, D. Hernandez, S. Arepalli, L. Malik, A. Miano-Burkhardt, H. Leonard, H. Iwaki, C. Blauwendraat, A. Singleton, S. Bandres-Ciga (Bethesda, USA)

The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

N. Louie, J. Solle, S. Bandrés-Ciga (New York, USA)

The functional consequences of the ‘African GBA1 allele’ of rs3115534 in Parkinson’s Disease

M. Radefeldt, L. Demuth, R. Al-Ali, S. Fischer, C. Beetz, P. Bauer (Rostock, Germany)

The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach

AT. Cimmino, P. Sanginario, F. Musso, D. Genovese, A. de Biase, M. Petracca, F. Bove, C. Piano, FD. Tiziano, AR. Bentivoglio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.

M. Alborghetti, E. Bianchini, D. Rinaldi, I. de Bartolo, L. Di Menna, G. Battaglia, V. Bruno, T. Esposito, M. Borro, M. Simmaco, F. Pontieri, A. Berardelli, F. Nicoletti (Rome, Italy)

the role of the “unfolded protein response” and the perk pathway in parkinson’s disease: study of genetic polymorphisms

N. Palomba, E. Bianchini, D. Rinaldi, C. Strafella, V. Caputo, F. Garramone, P. Lombardo, F. Nicoletti, E. Giardina, T. Esposito, F. Pontieri, M. Alborghetti ()

Transcriptome analysis of proteasome and inflammation in the substantia nigra of Parkinson’s disease patients: the GEO database.

TL. Ho, HD. Nguyen, EJ. Ko, YE. Kim (Jeju-si, Republic of Korea)

Understanding Parkinson’s disease in Spain: genetic and clinical insights

M. Martín-Bornez, L. Muñoz-Delgado, R. Diaz-Belloso, MT. Periñán, M. Bonilla-Toribio, D. Buiza-Rueda, D. Macías-García, S. Jesús, A. Adarmes-Gómez, E. Ojeda, A. Luque-Ambrosiani, S. García-Díaz, R. Pineda, F. Carrillo, P. Mir, P. Gómez-Garre (Seville, Spain)

Understanding the earliest phases of Parkinson’s disease (PD) – an expanding opportunity to study ‘at-risk’/early/prodromal PD in the Global Parkinson’s Genetics Program (GP2)

K. Atterling Brolin, S. Jasaityte, M. Teferra, M. Rezaei, L. Jones, J. Trinh, E. Stafford, M. Makarious, M T. Periñan, L. Lange, S. Waters, A. Martinez Carrasco, M. Tan, H. Iwaki, H. Morris, C. Blauwendraat, A. Singleton, Z. Gan-Or, A. Noyce (Lund, Sweden)